Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Heart Journal

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ahj.2015.09.010PMID 26678639PMCID PMC4684596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improving Cardiovascular Risk Prediction in the General Population

  2015cited by this paper
• 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cited by this paper
• 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Application of new cholesterol guidelines to a population-based sample.

  2014cited by this paper
• Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial.

  2014cited by this paper
• Making Sense of High Sensitivity Troponin Assays and their Role in Clinical Care

  2014cited by this paper
• Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender.

  2013cited by this paper
• Statins: new US guideline sparks controversy.

  2013cited by this paper
• The global dominance of diabetes.

  2013cited by this paper
• Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.

  2013cited by this paper
• Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study

  2012cited by this paper
• N-terminal Pro-B-Type Natriuretic Peptide, Left Ventricular Mass, and Incident Heart Failure: Multi-Ethnic Study of Atherosclerosis

  2012cited by this paper
• Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

  2011cited by this paper
• N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese Community: The Hisayama Study

  2011cited by this paper
• Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.

  2010cited by this paper
• Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.

  2010cited by this paper
• Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts: The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project

  2010cited by this paper
• Amino-Terminal Pro–B-Type Natriuretic Peptide Improves Cardiovascular and Cerebrovascular Risk Prediction in the Population: The Rotterdam Study

  2010cited by this paper
• Does the Relationship Between Natriuretic Hormones and Diastolic Function Differ by Race?

  2009cited by this paper
• B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies

  2009cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

  2008cited by this paper
• Amino-terminal pro-B-type natriuretic peptide: analytic considerations.

  2008cited by this paper
• Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.

  2008cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• Reference ranges and diagnostic thresholds of laboratory markers of cardiac damage and dysfunction in a population of apparently healthy black Africans

  2008cited by this paper
• Unexplained week‐to‐week variation in BNP and NT‐proBNP is low in chronic heart failure patients during steady state

  2007cited by this paper
• Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA).

  2007cited by this paper
• Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide: Biomarkers for Mortality in a Large Community-Based Cohort Free of Heart Failure

  2006cited by this paper
• Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

  2006cited by this paper
• Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study

  2006cited by this paper
• N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

  2005cited by this paper
• Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

  2004cited by this paper
• Multi-Ethnic Study of Atherosclerosis: objectives and design.

  2002cited by this paper
• Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

  2001cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Clinical Research Prevention and Epidemiology N-terminal Pro-brain Natriuretic Peptide, but Not High Sensitivity C-reactive Protein, Improves Cardiovascular Risk Prediction in the General Population

  year unknowncited by this paper

• Factors influencing Systemic Coronary Risk Estimation 2 (SCORE2)

  2025cites this paper
• Predicting the rapid progression of coronary artery lesions in patients with acute coronary syndrome based on machine learning

  2025cites this paper
• Circulating cardiovascular biomarkers in motion: redefining cardiovascular risk with dynamic prediction.

  2025cites this paper
• NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients

  2025cites this paper
• Exposure to green spaces, cardiovascular risk biomarkers and incident cardiovascular disease in older adults: The Seniors-Enrica II cohort.

  2024cites this paper
• Post-acute COVID-19 syndrome: prevalence of peripheral microvascular endothelial dysfunction and associations with NT-proBNP dynamics.

  2024cites this paper
• Cardiovascular Risks and Outcomes Among Chinese American Immigrants: Insights From the Multi‐Ethnic Study of Atherosclerosis

  2024cites this paper
• Association of thyroid dysfunction in individuals ≥ 65 years of age with subclinical cardiac abnormalities.

  2024cites this paper
• Trajectories of cardiac troponin in the decades before cardiovascular death: a longitudinal cohort study

  2023cites this paper
• Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study.

  2023cites this paper
• Predictive Value of the Lipoprotein(a) to Prealbumin Ratio and of the NT-proBNP to LVEF Ratio for Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.

  2023cites this paper
• Subclinical Cardiovascular Disease in US Adults With and Without Diabetes

  2023cites this paper
• Long COVID Syndrome: A Case-Control Study

  2023cites this paper
• Sex Differences in Cardiac Troponin Trajectories Over the Life Course

  2023cites this paper
• Ignition ability prediction model of biomass fuel by arc beads using logistic regression

  2023cites this paper
• Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death.

  2023cites this paper
• Rational choice of the biochemical marker in a cohort study

  2022cites this paper
• Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High‐Sensitivity Troponin T, and N‐Terminal Pro–Brain‐Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction

  2022cites this paper
• Clinical predictors of acute cardiac injury and normalization of troponin after hospital discharge from COVID-19

  2022cites this paper
• Malignant Left Ventricular Hypertrophy and Epidemiology 101.

  2022cites this paper
• Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD

  2022cites this paper
• Evaluation of Mineralocorticoid Receptor Antagonism on Changes in NT-proBNP Among Persons With HIV

  2021cites this paper
• Associations of cardiac injury biomarkers with risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis.

  2021cites this paper
• A robust machine learning framework to identify signatures for frailty: a nested case-control study in four aging European cohorts

  2021cites this paper
• Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study).

  2021cites this paper
• Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease

  2020cites this paper
• High Sensitivity Troponin and the Risk of Atrial Fibrillation in Chronic Kidney Disease: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

  2020cites this paper
• Healthy diet reduces markers of cardiac injury and inflammation regardless of macronutrients: Results from the OmniHeart trial.

  2020cites this paper
• Biomarkers to Establish Low ASCVD Risk: It Takes Two.

  2020cites this paper
• Valid cardiac biochemical markers. Part II

  2020cites this paper
• CARDIOVASCULAR DISEASE RISK ASSESSMENT WITH HIGH-SENSITIVITY CARDIAC TROPONIN I AND OTHER BIOMARKERS: AN OBSERVATIONAL COHORT STUDY IN JOHOR, MALAYSIA

  2020cites this paper
• Change in NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Level and Risk of Dementia in Multi-Ethnic Study of Atherosclerosis (MESA)

  2019cites this paper
• High N-Terminal proB-Type Natriuretic Peptide Indicates Elevated Risk of Death after Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction

  2019influential citation
• Relation of Dietary Sodium Intake With Subclinical Markers of Cardiovascular Disease (from MESA).

  2019cites this paper
• Independent Impact of Gynoid Fat Distribution and Free Testosterone on Circulating Levels of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in Humans

  2019cites this paper
• Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study

  2019cites this paper
• Markers of Atherosclerosis: Part 1 - Serological Markers.

  2019cites this paper
• The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal

  2019cites this paper
• Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients

  2018cites this paper
• Objectively measured physical activity and cardiac biomarkers: A cross sectional population based study in older men

  2018cites this paper
• Novel biomarkers of cardiovascular disease: Applications in clinical practice

  2018cites this paper
• Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.

  2018cites this paper
• Prognostic implications of detectable cardiac troponin I below the 99th percentile in patients admitted to an emergency department without acute coronary syndrome

  2018cites this paper
• Fluorescence immunosensor for cardiac troponin T based on Förster resonance energy transfer (FRET) between carbon dot and MoS2 nano-couple.

  2018cites this paper
• Cardiovascular biomarkers in clinical studies of type 2 diabetes

  2018cites this paper
• Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis

  2017cites this paper
• Discrimination and Calibration of Clinical Prediction Models: Users’ Guides to the Medical Literature

  2017cites this paper
• N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study

  2017cites this paper
• The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study

  2017cites this paper
• HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease

  2017cites this paper
• Novel biomarkers for cardiovascular risk prediction

  2017cites this paper
• Association of high-sensitivity cardiac troponin T with mortality and cardiovascular events in a community-based prospective study in Beijing

  2017cites this paper
• Biochemical risk markers and 10‐year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification

  2017cites this paper
• High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis)

  2017cites this paper
• The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA).

  2017cites this paper
• High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer’s disease: the FINRISK Study

  2017cites this paper
• Air pollution exposure and novel biomarkers of inflammation and cardiac stress in the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air)

  2016cites this paper
• Cardiac troponins and prediction of coronary artery disease risk

  2016cites this paper
• Biomarkers of Key Biological Pathways in CVD.

  2016cites this paper
• Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies

  2016cites this paper